1029 related articles for article (PubMed ID: 32631294)
1. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen X; Meng F; Jiang R
Front Oncol; 2021; 11():746976. PubMed ID: 34900692
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
Yang T; Hao L; Yang X; Luo C; Wang G; Lin Cai C; Qi S; Li Z
BMJ Open; 2021 Sep; 11(9):e049123. PubMed ID: 34475167
[TBL] [Abstract][Full Text] [Related]
6. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Stroke: A Systematic Review and Meta-Analysis.
Li W; Hou M; Ding Z; Liu X; Shao Y; Li X
Front Neurol; 2021; 12():686983. PubMed ID: 34630275
[No Abstract] [Full Text] [Related]
8. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis.
Hu K; Lou L; Ye J; Zhang S
BMJ Open; 2015 Apr; 5(4):e006404. PubMed ID: 25854964
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
Kim SI; Kim SJ; Kim SJ; Cho DS
Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Nunno VD; Mollica V; Gatto L; Santoni M; Cosmai L; Porta C; Massari F
Immunotherapy; 2019 May; 11(7):631-643. PubMed ID: 30943858
[TBL] [Abstract][Full Text] [Related]
12. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab.
Roussel E; Kinget L; Verbiest A; Debruyne PR; Baldewijns M; Van Poppel H; Albersen M; Beuselinck B
Urol Oncol; 2021 Apr; 39(4):239.e17-239.e25. PubMed ID: 33485762
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma: A meta-analysis.
Yin J; Qin Y; Luo YK; Feng M; Lang JY
Medicine (Baltimore); 2017 Jul; 96(29):e7577. PubMed ID: 28723793
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in patients with laryngeal cancer: a systematic review and meta-analysis.
Yang F; Huang Q; Guan Z; Diao Q
Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):417-425. PubMed ID: 32886184
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.
Na N; Yao J; Cheng C; Huang Z; Hong L; Li H; Qiu J
Oncotarget; 2016 Jul; 7(28):44039-44046. PubMed ID: 27270655
[TBL] [Abstract][Full Text] [Related]
17. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
20. Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Pichler M; Hutterer GC; Stoeckigt C; Chromecki TF; Stojakovic T; Golbeck S; Eberhard K; Gerger A; Mannweiler S; Pummer K; Zigeuner R
Br J Cancer; 2013 Mar; 108(4):901-7. PubMed ID: 23385728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]